In a recent business intelligence study, Fact.MR presents the nitty-gritty of the global parenteral drugs market considering 2014-2018 as the historic year and 2019–2029 as the stipulated timeframe.
The business report highlights the drivers, restraints, opportunities and trends affecting parenteral drugs market growth.
Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.
Parenteral drugs are types of medications that require non-oral types of administration, mostly through the direct injection of drugs into the body of the patient either in intravenous, intramuscular, and subcutaneous methods.
As the complexity of active pharmaceutical ingredients goes up, and includes small molecule options and biologics, the number of parenteral drugs has gone up as well.
The number of new molecular products which have received the approval of regulatory bodies such as the FDA has gone up and has aided the growth of the industry for the foreseeable future.Asia Pacific Being Targeted by ManufacturersMajor pharmaceutical companies from around the world are seeking the acquisition of smaller regional competitors, particularly those in the emerging markets of the Asia Pacific region, with the aim of maintaining sustainable rates of growth in terms of parenteral drugs.Further hospital pharmacies are gaining importance as primary channels of distribution owing to higher rates of hospitalization and the rising availability of requisitely skilled man power resources.